ImmunoGen Inc (IMGN)

[vinmantoo]

As you probably know I'm also invested in NWBO. Their vaccine, DCVax-L, has been extensively tested in GBM, the survival advantage is spectacular when combined with other drugs, like Keytruda, which failed in GBM prior to being combined with DCVax-L. By itself DCVax-L raised 5 year survival by a factor of nearly 3 from 5% to about 14%, but add the other therapeutics and 50% or more are likely to live 5 years. The vaccine is made from the patients tumor and white cells. Like Elahere in other platinum resistant cases, DCVax-L has anecdotal evidence that it's effective in other solid cancers. I certainly don't know for certain that off label either will work, but the odds are actually pretty good that in at least some applications both of them will work.

Gary, I don't follow NWBO so maybe I should start. Thanks for the heads up.